Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 326.00
-5.00 (-1.51%)
Aug 10, 2026, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 23.25 billion as of August 10, 2026. Its market cap has decreased by -0.45% in one year.
Market Cap
23.25B
Enterprise Value
9.20B
Revenue
9.24B
Ranking
n/a
PE Ratio
3.70
Stock Price
326.00
ChartMarket Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 23.25B, an increase of 1,553.89%. That is a compound annual growth rate of 19.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 23.25B | -29.23% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.35T |
| Genmab | 119.34B |
| Coloplast | 98.51B |
| Demant | 59.52B |
| ALK-Abelló | 49.63B |
| H. Lundbeck | 40.02B |
| Ambu A/S | 19.37B |
| GN Store Nord | 14.39B |